Chuck Harbert

Chuck Harbert, Ph.D. worked for 30 years with Pfizer Central Research. Prior to his retirement from Pfizer he was Vice President of US Exploratory Development and Head of Project Management and Strategic Planning. He has broad and deep experience in drug discovery and early development through Phase II proof of concept. He led the chemistry team that discovered Zoloft, a highly successful antidepressant drug, and CP-55,940, a highly potent cannabinoid that was utilized by NIH scientists to elaborate the endocannabinoid receptor system. Chuck received the Pfizer Achievement Award in 1998, and he and the Zoloft discovery team were awarded the American Chemical Society “Team Innovation Award” in 2006. He was endorsed in 2017 by Who’s Who as a Lifetime Achiever in the pharmaceutical industry. He completed an NIH Postdoctoral Fellowship at Stanford University after earning his Ph.D. in Organic Chemistry from the University of Missouri.